Login to Your Account

Roche Inks $595M Deal for Chiasma's Acromegaly Drug

By Catherine Shaffer
Staff Writer

Wednesday, February 20, 2013
A partnership between Roche AG and Chiasma Inc., of New York, promises to take the pain out of therapy for acromegaly, the overproduction of growth hormone.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription